In the end, it all came down to Nike
(NKE), Greek Goddess of Victory, versus Aphrodite, Cypriot Goddess of Beauty. An 8.7% surge in the athletic apparel outfit essentially evened out economic turmoil on the Mediterranean island and stocks ended the week basically where they began.
If Nike’s advance to a new record was better news for Tiger Woods than his new girlfriend
, any future trips to Tiffany
(TIF) should prove equally profitable for the couple after the wedding ring king jumped 1.94% on Friday. Cyprus, whose soccer side were long sponsored by arch rival Adidas
(PINK:ADDYY), must regard it all as a real kick in the teeth.
Meanwhile, on this side of the Atlantic, investors wonder why all the fuss on a country whose gross domestic product is only $23 billion, or what Warren Buffett spends on ketchup
. The Dow
(^DJI) dropped a mere 0.01% on the week, a photo finish that was just fine for Shutterstock
(SSTK), which gained 11%, and Shutterfly
(NASDAQ:SFLY), begun with a bullish research rating this morning.
It’s a second straight session without any top-tier economic data, but earnings action includes Apollo Group
(APOL), Dollar General
(DG), Focus Media
(FMCN), JA Solar
(JASO), and Sonic Corporation
(AIXG): Shares are assigned an Outperform by BNP Paribas.
(BRS): JPMorgan initiates the air services outfit at Overweight.
(CMCSA): The cable company is covered with a Buy at Goldman Sachs on account of its “superior fundamental business mix.”
Corporate Executive Board
(CEB): SunTrust Robinson Humphrey starts the stock at a Buy.
Eagle Rock Energy
(EROC): Shares are assigned a Market Perform with Wells Fargo.
(GALE): The biotech is begun with a Buy at Needham, whose price objective is $3.50. NeuVax, its vaccine in development to treat breast cancer, shows considerable promise. Shares are surging more than 6% ahead of the open as a result.
Rentech Nitrogen Partners
(RNF) Goldman resumes Neutral rated research on RNF.
(NASDAQ:SFLY): The digital photo powerhouse is begun with a Buy at Needham, whose target price is $52. Catalysts include compelling product launches and a market-leading position.
(See also: Stock Upgrades: You’re In Good Hands With Allstate
and Stock Downgrades: Cash Is Not JC Penney’s Middle Name
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.